Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.41 | 1 | 1 |
Echinococcus granulosus | cyclic nucleotide gated cation channel alpha 3 | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.055 | 0.1305 | 0.1305 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0035 | 0.0043 | 0.0043 |
Brugia malayi | putative amidase | 0.0495 | 0.1168 | 0.1168 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0113 | 0.0235 | 0.1141 |
Echinococcus granulosus | voltage gated potassium channel | 0.0035 | 0.0043 | 0.0043 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0035 | 0.0043 | 0.0043 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0035 | 0.0043 | 0.0043 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0495 | 0.1168 | 0.1168 |
Mycobacterium leprae | PROBABLE AMIDASE AMIC (AMINOHYDROLASE) | 0.0495 | 0.1168 | 0.5 |
Mycobacterium ulcerans | amidase | 0.0495 | 0.1168 | 1 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel alpha 3 | 0.0024 | 0.0016 | 0.0016 |
Mycobacterium tuberculosis | Probable amidase AmiC (aminohydrolase) | 0.0495 | 0.1168 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0807 | 0.1934 | 1 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.41 | 1 | 1 |
Mycobacterium leprae | PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE (SUBUNIT A) GATA (Glu-ADT SUBUNIT A) | 0.0495 | 0.1168 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0105 | 0.0215 | 0.0215 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0495 | 0.1168 | 0.1168 |
Mycobacterium ulcerans | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0495 | 0.1168 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0495 | 0.1168 | 0.5 |
Schistosoma mansoni | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0495 | 0.1168 | 0.1168 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | cyclic-nucleotide gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | cyclic-nucleotide gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0121 | 0.0254 | 0.0254 |
Trypanosoma cruzi | amidase, putative | 0.0495 | 0.1168 | 0.5 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0024 | 0.0016 | 0.0016 |
Mycobacterium ulcerans | amidase | 0.0495 | 0.1168 | 1 |
Plasmodium vivax | glutamyl-tRNA(Gln) amidotransferase subunit A, putative | 0.0495 | 0.1168 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0024 | 0.0016 | 0.0016 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0113 | 0.0235 | 0.1141 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | amidase | 0.0495 | 0.1168 | 0.1168 |
Mycobacterium ulcerans | amidase | 0.0495 | 0.1168 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.055 | 0.1305 | 0.1305 |
Echinococcus granulosus | Zinc finger DBF type | 0.0807 | 0.1934 | 0.1934 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0019 | 0.0004 | 0.0004 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0043 | 0.0043 |
Leishmania major | hypothetical protein, conserved | 0.0495 | 0.1168 | 1 |
Schistosoma mansoni | amidase | 0.41 | 1 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0035 | 0.0043 | 0.0043 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.41 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.3698 | 0.9013 | 0.9013 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0121 | 0.0254 | 0.0254 |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0024 | 0.0016 | 0.0016 |
Brugia malayi | Protein kinase domain containing protein | 0.055 | 0.1305 | 0.1305 |
Echinococcus multilocularis | Zinc finger, DBF type | 0.3698 | 0.9013 | 0.9013 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0132 | 0.0282 | 0.0282 |
Mycobacterium tuberculosis | Probable amidase AmiB2 (aminohydrolase) | 0.0495 | 0.1168 | 1 |
Mycobacterium tuberculosis | Probable amidase AmiA2 (aminohydrolase) | 0.0495 | 0.1168 | 1 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0024 | 0.0016 | 0.0016 |
Brugia malayi | Amidase family protein | 0.0495 | 0.1168 | 0.1168 |
Trypanosoma cruzi | amidase, putative | 0.0495 | 0.1168 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.41 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0035 | 0.0043 | 0.0043 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0495 | 0.1168 | 0.1168 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0016 | 0.0016 |
Loa Loa (eye worm) | amidase | 0.0495 | 0.1168 | 0.1168 |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0024 | 0.0016 | 0.0016 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0035 | 0.0043 | 0.0043 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Trypanosoma brucei | fatty-acid amide hydrolase, putative | 0.0495 | 0.1168 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0495 | 0.1168 | 0.5 |
Schistosoma mansoni | 60S ribosomal protein L21 | 0.0019 | 0.0004 | 0.0004 |
Mycobacterium ulcerans | peptide amidase, GatA | 0.0495 | 0.1168 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.41 | 1 | 1 |
Plasmodium falciparum | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0495 | 0.1168 | 1 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0495 | 0.1168 | 0.5 |
Toxoplasma gondii | protein kinase G AGC kinase family member PKG | 0.0018 | 0 | 0.5 |
Brugia malayi | Cyclic-nucleotide gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Mycobacterium tuberculosis | Probable amidase AmiD (acylamidase) (acylase) | 0.0495 | 0.1168 | 1 |
Echinococcus granulosus | potassium:sodium hyperpolarization activated | 0.0024 | 0.0016 | 0.0016 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0807 | 0.1934 | 1 |
Mycobacterium ulcerans | amidase | 0.0495 | 0.1168 | 1 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Echinococcus granulosus | glutamyl tRNAGln amidotransferase subunit A | 0.0495 | 0.1168 | 0.1168 |
Loa Loa (eye worm) | hypothetical protein | 0.41 | 1 | 1 |
Mycobacterium ulcerans | amidase | 0.0495 | 0.1168 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0132 | 0.0282 | 0.0282 |
Echinococcus multilocularis | glutamyl tRNA(Gln) amidotransferase subunit A | 0.0495 | 0.1168 | 0.1168 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0121 | 0.0254 | 0.0254 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0024 | 0.0016 | 0.0016 |
Brugia malayi | Amidase family protein | 0.0495 | 0.1168 | 0.1168 |
Mycobacterium tuberculosis | Possible amidase (aminohydrolase) | 0.0495 | 0.1168 | 1 |
Echinococcus multilocularis | potassium:sodium hyperpolarization activated | 0.0024 | 0.0016 | 0.0016 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0121 | 0.0254 | 0.0254 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ILS (functional) | = 29.9 % | Percent increase in life span at dose 20 mg/kg/day in 10 mice implanted with P388 leukemia cell line | ChEMBL. | 4020828 |
ILS (functional) | = 49.5 % | Percent increase in life span at dose 50 mg/kg/day in 10 mice implanted with P388 leukemia cell line | ChEMBL. | 4020828 |
ILS (functional) | = 49.5 % | Percent increase in life span at dose 60 mg/kg/day in 10 mice implanted with P388 leukemia cell line | ChEMBL. | 4020828 |
ILS (functional) | = 49.5 % | Percent increase in life span at dose 70 mg/kg/day in 10 mice implanted with P388 leukemia cell line | ChEMBL. | 4020828 |
ILS (functional) | = 53.3 % | Percent increase in life span at dose 40 mg/kg/day in 10 mice implanted with P388 leukemia cell line | ChEMBL. | 4020828 |
Survivors (functional) | = 0 | Number of survivors on 30th day at dose 20 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 0 | Number of survivors on 30th day at dose 70 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 0 | Number of survivors on 60th day at dose 20 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 0 | Number of survivors on 60th day at dose 50 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 0 | Number of survivors on 60th day at dose 70 mg/kg/day in 10 mice implanted with P388 leukemia cell line | ChEMBL. | 4020828 |
Survivors (functional) | = 1 | Number of survivors on 30th day at dose 40 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 1/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 1 | Number of survivors on 30th day at dose 50 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 1/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 1 | Number of survivors on 60th day at dose 40 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 1/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 2 | Number of survivors on 60th day at dose 60 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 2/10 | ChEMBL. | 4020828 |
Survivors (functional) | = 3 | Number of survivors on 30th day at dose 60 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 3/10 | ChEMBL. | 4020828 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.